Liver Diseases Global Clinical Trials Review  H2  2017

Liver Diseases Global Clinical Trials Review H2 2017


  • Products Id :- GDHC4717CTIDB
  • |
  • Pages: 1009
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Liver Diseases Global Clinical Trials Review, H2, 2017

Summary

GlobalData'sclinical trial report, �Liver Diseases Global Clinical Trials Review, H2, 2017" provides an overview of Liver Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents

List of Tables

List of Figures

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Liver Diseases to Gastrointestinal Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Liver Diseases to Gastrointestinal Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Liver Diseases Therapeutics Clinical Trials

Prominent Drugs

Latest Clinical Trials News on Liver Diseases

Nov 13, 2017: AdAlta to present at Anti-Fibrotic Drug Development Summit in Boston

Oct 23, 2017: Arrowhead Presents Promising Preclinical Data on Development of ARO-AAT for Treatment of Alpha-1 Liver Disease at Liver Meeting 2017

Oct 10, 2017: Arrowhead Pharmaceuticals to Present Preclinical Data on ARO-AAT at The Liver Meeting

Oct 10, 2017: Dova Pharmaceuticals to Present Phase 3 Avatrombopag Data at the 2017 Liver Meeting of the American Association for the Study of Liver Diseases

Oct 03, 2017: Final Results of Albireos Phase 2 Study of A4250 in Children with Cholestatic Liver Disease to be Presented at The Liver Meeting 2017

Sep 25, 2017: Alnylam Continues Leadership in RNAi Technologies and Delivery with New Pre-Clinical Data Presented on "Enhanced Stabilization Chemistry Plus" GalNAc-siRNA Conjugate Platform at 13th Annual Meeting of the Oligonucleotide Therapeutics Society

Clinical Trial Profile Snapshots 3

Appendix 100

Abbreviations 100

Definitions 100

Research Methodology 100

Secondary Research 100

About GlobalData 100

Contact Us 100

Source 100

List of Figures

Liver Diseases Therapeutics, Global, Clinical Trials by Region (%), 2017*

Liver Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*

Liver Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*

Liver Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017*

Liver Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017*

Liver Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2017*

Liver Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017*

Liver Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017*

Proportion of Liver Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2017*

Liver Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*

Liver Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*

Proportion of Liver Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2017*

Liver Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*

Liver Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*

Liver Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2017*

Liver Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2017*

Liver Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016

Liver Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017*

Liver Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

GlobalData Methodology 100

List of Tables

Liver Diseases Therapeutics, Global, Clinical Trials by Region, 2017*

Liver Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017*

Liver Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017*

Liver Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017*

Liver Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2017*

Liver Diseases Therapeutics Clinical Trials, North America, Top Countries, 2017*

Liver Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017*

Liver Diseases Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017*

Proportion of Liver Diseases to Gastrointestinal Clinical Trials, G7 Countries (%), 2017*

Liver Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2017*

Liver Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017*

Proportion of Liver Diseases to Gastrointestinal Clinical Trials, E7 Countries (%), 2017*

Liver Diseases Therapeutics, E7 Countries, Clinical Trials by Phase, 2017*

Liver Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017*

Liver Diseases Therapeutics, Global, Clinical Trials by Phase, 2017*

Liver Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2017*

Liver Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016

Liver Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017*

Liver Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017*

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Novartis AG

Pfizer Inc

Gilead Sciences Inc

Merck & Co Inc

GlaxoSmithKline Plc

F. Hoffmann-La Roche Ltd

Conatus Pharmaceuticals Inc

AstraZeneca Plc

C. H. Boehringer Sohn AG & Co KG

Bristol-Myers Squibb Co

select a license
Single User License
USD 2500 INR 171975
Site License
USD 5000 INR 343950
Corporate User License
USD 7500 INR 515925

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com